General
Preferred name
SSAA09E1
Synonyms
1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide ()
P&D ID
PD133543
CAS
433212-75-0
Tags
available
drug candidate
Drug indication
Discovery agent
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION SSAA09E1 is a cathepsin L blocker (IC50: 5.33 ¦ÌM).SSAA09E1 inhibits stages of viral entry. SSAA09E1 can be used for SARS-CoV infection research[1]
Compound Sets
3
Cayman Chemical Bioactives
DrugMAP
MedChem Express Bioactive Compound Library
External IDs
7
Properties
(calculated by RDKit )
Molecular Weight
199.02
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
1.31
TPSA
50.41
Fraction CSP3
0.14
Chiral centers
0.0
Largest ring
5.0
QED
0.43
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Cathepsin
SARS-CoV
Pathway
Anti-infection
Metabolic Enzyme/Protease
Source data